Last reviewed · How we verify
NCT04577768
The Effect of Transcranial Direct Current Stimulation on Motor Performance in Healthy Adults
NA trial testing HD-tDCS 2 mA in Healthy in 60 participants. Completed in 10 February 2020.
10 February 2020
Quick facts
| Lead sponsor | Ariel University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 11 July 2019 |
| Primary completion | 10 February 2020 |
| Estimated completion | 10 February 2020 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- HD-tDCS 2 mA
- HD-tDCS 1.5 mA
- HD-tDCS sham
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Ariel University
Who can join
Adults 20 to 35, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to investigate the effect of stimulation intensity on motor performance in healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of high-definition transcranial direct current stimulation intensity on motor performance in healthy adults: a randomized controlled trial.
Lerner O, Friedman J, Frenkel-Toledo S. · · 2021 · cited 20× · PMID 34174914 · DOI 10.1186/s12984-021-00899-z
Verify or expand the search:
- PubMed search for NCT04577768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Ariel University trials
Trials by the same sponsor.
- NCT06431308 — Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events · NA · recruiting
- NCT06828900 — Empowering Caregivers in ADHD Treatment: Standard Care Vs. Decision Aid, Coaching, and AI Support · NA · enrolling by invitation
- NCT06575465 — Evaluating Family & Community-Based Interventions to Improve Treatment Adherence in Metabolic Health Among Negev Bedouin · NA · recruiting
- NCT07531212 — Movement-Sequence Observation in Healthy Adults: Motor and Cognitive Effects on Effector-Independent Performance · NA · completed
- NCT06192537 — Examining the Effect of Role-playing Exercise by Utilizing an Obesity Suit in a Simulation Scenario on Weight Bias and E · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04577768 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ariel University
- Last refreshed: 8 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04577768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing